
11 - 50 employees
đ¤ Artificial Intelligence
đ§Ź Biotechnology
đŹ Science
Artificial Intelligence ⢠Biotechnology ⢠Science
Deep Origin is a cutting-edge company focused on accelerating research and development in the life sciences through its innovative platform and tools. It offers a molecular simulation toolkit and R&D platform that harness the power of artificial intelligence and seamless data management. Deep Origin's solutions are designed to help scientists tackle complex biological and disease-related challenges by providing tools for data analysis, molecular simulation, and drug discovery. The company aims to revolutionize computational biology and simulate biological processes to aid in discovering new therapies and understanding diseases. Deep Origin's offerings include AI-driven analysis assistants, high-performance workstations, and virtual drug screening capabilities, making it a powerful ally for interdisciplinary scientific research and development.
đ March 30
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
đ¤ Artificial Intelligence
đ§Ź Biotechnology
đŹ Science
Artificial Intelligence ⢠Biotechnology ⢠Science
Deep Origin is a cutting-edge company focused on accelerating research and development in the life sciences through its innovative platform and tools. It offers a molecular simulation toolkit and R&D platform that harness the power of artificial intelligence and seamless data management. Deep Origin's solutions are designed to help scientists tackle complex biological and disease-related challenges by providing tools for data analysis, molecular simulation, and drug discovery. The company aims to revolutionize computational biology and simulate biological processes to aid in discovering new therapies and understanding diseases. Deep Origin's offerings include AI-driven analysis assistants, high-performance workstations, and virtual drug screening capabilities, making it a powerful ally for interdisciplinary scientific research and development.
⢠Own, define, and scale our computational toxicology platform end-to-end. ⢠Operate as the general manager of the platform with full ownership across scientific vision, technical architecture, product strategy, and execution. ⢠Work cross-functionally with ML/AI teams, computational biologists, toxicologists, engineers, and commercial teams. ⢠Translate cutting-edge science into scalable, enterprise-ready systems. ⢠Define and drive the long-term roadmap for in silico toxicity prediction. ⢠Design innovative modeling approaches across mechanistic and ML paradigms. ⢠Integrate ML/AI, systems biology, PK/PD modeling, and real-world data into a unified platform. ⢠Evaluate tradeoffs between mechanistic modeling and statistical learning approaches. ⢠Identify breakthrough opportunities beyond current industry standards. ⢠Translate scientific capabilities into robust, scalable software systems. ⢠Partner closely with engineering to build secure, enterprise-grade infrastructure. ⢠Ensure scientific rigor, reproducibility, and regulatory alignment. ⢠Define product strategy for pharma-facing platform offerings. ⢠Engage directly with senior R&D and safety leaders at pharmaceutical companies. ⢠Build and lead a world-class interdisciplinary team (ML scientists, computational biologists, toxicologists, engineers).
⢠15+ years in computational biology, toxicology, drug discovery, or related domain. ⢠Proven experience designing and deploying computational models for toxicity or biological systems. ⢠Demonstrated ability to develop novel modeling approaches beyond industry-standard methods. ⢠Deep hands-on experience designing and deploying computational toxicology models across mechanistic, statistical, and machine learning paradigms. ⢠Demonstrated ability to design innovative modeling approaches, not just apply existing frameworks. ⢠Expertise in integrating ML/AI, systems biology, PK/PD modeling, and real-world data into cohesive predictive systems. ⢠Strong track record evaluating tradeoffs between mechanistic modeling and statistical/ML approaches. ⢠Ability to identify breakthrough opportunities beyond current industry standards. ⢠Experience developing novel model architectures, not just QSAR or legacy approaches. ⢠Comfortable discussing mechanistic toxicity pathways, ML architectures, regulatory strategy, and platform design. ⢠Deep expertise in one or more of: ⢠- Predictive/computational toxicology. ⢠- Systems pharmacology or systems biology. ⢠- Mechanistic modeling. ⢠- ML/AI in drug discovery. ⢠- PK/PD or ADMET modeling. ⢠Strong understanding of preclinical safety workflows. ⢠Familiarity with regulatory frameworks (FDA, EMA, ICH). ⢠Experience working with complex and proprietary pharma datasets. ⢠Awareness of data limitations, bias, and validation challenges. ⢠Experience leading large, interdisciplinary technical teams. ⢠Ability to operate as both a strategic leader and a technical decision-maker. ⢠Executive presence with senior pharma stakeholders. ⢠Strong communication and cross-functional leadership skills. ⢠Experience building platforms, teams, or systems from zero to scale. ⢠Comfortable operating in ambiguity and defining direction. ⢠Strong bias toward action, ownership, and iteration.
⢠Opportunity to define the future of drug safety and predictive toxicology. ⢠Competitive compensation package with meaningful equity. ⢠Comprehensive health, dental, and vision coverage. ⢠Remote-friendly culture with optional onsite work. ⢠Annual team gatherings and company events.
Apply Nowđ March 29
51 - 200
VP of Credit Risk & Analytics optimizing credit portfolio and defining strategies for growth and profitability at Greenbox Capital. Leading credit policy, pricing, and analytics team to drive impactful decisions.
đ March 28
Vice President of Commercial Enablement overseeing commercial strategies focused on lead generation and sales growth at CTI. Collaborates extensively with Marketing, SMEs, and executive leadership to ensure alignment and impact.
đ March 27
Vice President of Technology leading a remote engineering team for a mission-driven edtech startup. Overseeing technology and cybersecurity and driving software development for educational products.
đ March 27
VP - Regional Manager at UFG Insurance driving underwriting strategy and profitable growth in the Southeast Region. Leading teams and managing agency relationships in Alabama, Florida, Mississippi, and Tennessee.
đ March 26
Vice President leading expansion strategy and launch of new Chapters for Blue Star Families non-profit organization. Collaborating with senior leaders to enhance military family support across communities.